Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Share-based Compensation (2021 - 2026)

Nexalin Technology (NXL) posted Share-based Compensation of $4.1 million for Q2 2026, little changed on a QoQ basis from $4.1 million in Q1 2026, and up 35.4% year-over-year from $3.0 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Share-based Compensation (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Share-based Compensation for 6 years, with the latest figure at $4.1 million in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 35.4% year-over-year to $4.1 million in Q2 2026; TTM through Jun 2026 was $4.1 million, a 35.4% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 15.53% from the prior year.
  • Share-based Compensation was $4.1 million for Q2 2026 at Nexalin Technology, roughly flat from $4.1 million in the prior quarter.
  • The five-year high for Share-based Compensation was $4.1 million in Q1 2026, with the low at -$182049.0 in Q4 2022.
  • Average Share-based Compensation over 5 years is $1.8 million, with a median of $1.9 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Share-based Compensation sank 251.7% in 2022, then surged 166339.02% in 2024.
  • Over 5 years, Share-based Compensation stood at -$182049.0 in 2022, then jumped by 1353.44% to $2.3 million in 2023, then sank by 32.0% to $1.6 million in 2024, then tumbled by 46.41% to $831529.0 in 2025, then soared by 394.71% to $4.1 million in 2026.
  • The last three Share-based Compensation figures came in at $4.1 million (Q2 2026), $4.1 million (Q1 2026), and $831529.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 168.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 67.10 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 125.00 Mn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 7.00 Mn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 61.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 42.20 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 42.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 39.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 12.80 Mn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 4.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.11 Mn
Mar 31, 2026 4.11 Mn
Dec 31, 2025 831,529.00
Sep 30, 2025 3.91 Mn
Jun 30, 2025 3.04 Mn
Mar 31, 2025 3.07 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 2.86 Mn
Jun 30, 2024 2.28 Mn
Mar 31, 2024 2.28 Mn
Dec 31, 2023 2.28 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 88,388.00
Mar 31, 2023 1,371.00
Dec 31, 2022 -182,049.00
Sep 30, 2022 184,291.00
Jun 30, 2022 171,600.00
Mar 31, 2022 97,500.00
Dec 31, 2021 120,002.00
Sep 30, 2021 1.49 Mn